Tivozanib

Farmaco sperimentale inibitore c-Met - hepatocyte growth factor receptor (HGFR)

Trial clinico italiano http://www.aiom.it/studi%2Dclinici/ricerca%2Dstudi%2Dclinici/tivo3-studio-randomizzato-di-fase-iii-controllato-multicentrico-in-aperto-volto-ad-effettuate-confronto-tra-tivozanib-e-sorafenib-in-pazienti-con-carc/6-511-4427

http://www.ascopost.com/issues/february-10-2016/expert-point-of-view-sumanta-k-pal-md/